Fiona Sutherland - 30 Jul 2025 Form 4 Insider Report for ACUREN CORP (TIC)

Role: GENERAL COUNSEL
Signature: /s/ Fiona Sutherland
Issuer symbol: TIC
Transactions as of: 30 Jul 2025
Net transactions value: -$54,960
Form type: 4
Filing time: 01 Aug 2025, 18:05:05 UTC
Previous filing: 15 Apr 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
SUTHERLAND FIONA	GENERAL COUNSEL	C/O ACUREN CORPORATION, 14434 MEDICAL COMPLEX DRIVE, SUITE 100, TOMBALL	/s/ Fiona Sutherland	01 Aug 2025	0002042443

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TIC	Common Stock	Options Exercise	$0	+10,000		$0.000000	10,000	30 Jul 2025	Direct	F1
transaction	TIC	Common Stock	Tax liability	$54,960	-4,800	-48%	$11.45	5,200	30 Jul 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TIC	Restricted Stock Units	Options Exercise	$0	-10,000	-33%	$0.000000	20,000	30 Jul 2025	Common Stock	10,000		Direct	F3, F4
holding	TIC	Performance Based Restricted Stock Units						30,000	30 Jul 2025	Common Stock	30,000		Direct	F5, F6
holding	TIC	Restricted Stock Units						20,000	30 Jul 2025	Common Stock	20,000		Direct	F3, F7
holding	TIC	Performance Based Restricted Stock Units						40,000	30 Jul 2025	Common Stock	40,000		Direct	F5, F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On July 30, 2025, 10,000 of the Reporting Person's restricted stock units were settled for an equal number of shares of the Issuer's Common Stock.
F2	Shares withheld for tax liability.
F3	Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F4	These restricted stock units vest 33 1/3% on the first through third anniversaries of the grant date (July 30, 2024).
F5	Each performance based restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F6	Subject to the volume weighted average price ("VWAP") of the Issuer's Common Stock reaching a specified price over a ten (10) consecutive trading day period at any time during the period commencing on February 18, 2025 and ending on July 30, 2029 (the "VWAP Achievement Period"), these performance based restricted stock units shall vest on the later of (x) July 30, 2025 and (y) the calendar day following the last day of the VWAP Achievement Period.
F7	These restricted stock units vest on the third anniversary of the grant date (April 11, 2025).
F8	These performance based restricted stock units have a three-year performance period and to the extent earned will vest on April 11, 2028. The number of shares of Common Stock that will be earned is subject to decrease based on the result of the performance condition.